These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36510571)

  • 1. Corporate donation behavior during the covid-19 pandemic. A case-study approach in the multinational inditex.
    Galan-Ladero MM; Sánchez-Hernández MI
    Heliyon; 2022 Dec; 8(12):e12188. PubMed ID: 36510571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
    Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
    Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of hotel CSR for strategic philanthropy on booking behavior and hotel performance during the COVID-19 pandemic.
    Shin H; Sharma A; Nicolau JL; Kang J
    Tour Manag; 2021 Aug; 85():104322. PubMed ID: 34815613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nexus between corporate social responsibility and firm's perceived performance: evidence from SME sector of developing economies.
    Yumei H; Iqbal W; Nurunnabi M; Abbas M; Jingde W; Chaudhry IS
    Environ Sci Pollut Res Int; 2021 Jan; 28(2):2132-2145. PubMed ID: 32875447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical leadership, corporate social responsibility, firm reputation, and firm performance: A serial mediation model.
    Nguyen NTT; Nguyen NP; Thanh Hoai T
    Heliyon; 2021 Apr; 7(4):e06809. PubMed ID: 33898855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond COVID-19 Pandemic: An Integrative Review of Global Health Crisis Influencing the Evolution and Practice of Corporate Social Responsibility.
    Asante Antwi H; Zhou L; Xu X; Mustafa T
    Healthcare (Basel); 2021 Apr; 9(4):. PubMed ID: 33921512
    [No Abstract]   [Full Text] [Related]  

  • 9. Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.
    Dănescu T; Popa MA
    Global Health; 2020 Dec; 16(1):117. PubMed ID: 33302949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational health and safety of multinational construction companies through evaluation of corporate social responsibility reports.
    Mavroulidis M; Vouros P; Fotiadis S; Konstantakopoulou F; Fountoulakis G; Nikolaou I; Evangelinos K
    J Safety Res; 2022 Jun; 81():45-54. PubMed ID: 35589305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. Fortune 500's stakeholders engagement during the COVID-19 pandemic: Evidence for proactive approaches.
    Yang A; Sun J; Taylor M
    Public Relat Rev; 2022 Nov; 48(4):102230. PubMed ID: 35910261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Relationship Between Corporate Social Responsibility, Trust, Corporate Reputation, and Brand Equity.
    Zhao Y; Abbas M; Samma M; Ozkut T; Munir M; Rasool SF
    Front Psychol; 2021; 12():766422. PubMed ID: 34858294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corporate responses to the COVID-19 pandemic by Fortune 500 companies.
    Parmelee SD; Greer CF
    Public Relat Rev; 2023 Mar; 49(1):102285. PubMed ID: 36589151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the association of environmental, corporate, financial, and social CSR: evidence from fuzzy TOPSIS nexus in emerging economies.
    Kamran HW; Pantamee AA; Patwary AK; Ghauri TA; Long PD; Nga DQ
    Environ Sci Pollut Res Int; 2021 Mar; 28(9):10749-10762. PubMed ID: 33099740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discursive construction of corporate identity in the corporate social responsibility reports: A case study of Starbucks.
    Li X
    Front Psychol; 2022; 13():940541. PubMed ID: 36092082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.
    Popkova E; DeLo P; Sergi BS
    Res Int Bus Finance; 2021 Jan; 55():101315. PubMed ID: 34173410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of COVID-19 on business perspectives of sustainable development and corporate social responsibility in China.
    Zhang D; Lu S; Morse S; Liu L
    Environ Dev Sustain; 2022; 24(6):8521-8544. PubMed ID: 34548843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific evolution of Corporate Social Responsibility. A bibliometric analysis with mapping analysis tools.
    Escamilla-Solano S; Paule-Vianez J; Plaza-Casado P; Díaz-Iglesias S
    An Acad Bras Cienc; 2023; 95(1):e20210215. PubMed ID: 36946802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR.
    Fooks G; Gilmore A; Collin J; Holden C; Lee K
    J Bus Ethics; 2013 Jan; 112(2):283-299. PubMed ID: 23997379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.